Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but without diabetes, according to a study published online Jan. 21 in JAMA Network ...

Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...

The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...

The condition is better measured by looking at factors like inflammation, insulin resistance, and glucose tolerance, ...

The team categorized pediatric obesity treatment response, based on changes in body mass index standard deviation score, as ...

An international team of doctors proposed a new way to define obesity that's not based solely on BMI. Here's what they ...

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher ...

BROWNSVILLE — It was an unusually cold Saturday morning in the Rio Grande Valley but that didn't stop hundreds of people from forming a line that wound throughout the south side of the Brownsville ...

Explore how turmeric, yoga, bathua, natural yoghurt, and jackfruit can help manage prediabetes. Find out the benefits of ...

A retrospective study demonstrated slightly elevated baseline fasting plasma glucose levels to be a robust marker of incident diabetes risk, even when those levels fell within the normal range.

A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...

A global group of experts has suggested a new approach to diagnosing and treating obesity that does not rely solely on the ...